Novartis targets oncologists with blog

Novartis is experimenting with blogging for physicians with melanomaperspectives.com.
Executed by Compass Healthcare Communications, it went live in August with a panel of five knowledge and opinion leader contributors.

Though the site is unbranded, Novartis hopes to educate referring and community oncologists about the benefits of interleukin-2 therapies like the company's Proleukin, for metastatic melanoma and metastatic kidney cancer. A late-stage treatment, Proleukin suffers from a lack of awareness regarding the timing and usage of immunotherapy versus chemotherapy.

As the site does not have comments, Novartis doesn't have to worry about the thorny issue of adverse events reporting. All content is reviewed by the company for medical, regulatory and legal correctness before posting. It will be supported by search engine optimization, details and banner ads.  

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.